Intravenous valproate loading in acutely manic and depressed bipolar I patients

Journal of Clinical Psychopharmacology

Volumn 19, Issue 4, 1999, Pages 303-309

  Grunze, Heinz ^a   Erfurth, Andreas ^a   Amann, Benedikt ^a   Giupponi, Giancarlo ^a   Kammerer, Christine ^a   Walden, Jörg ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; VALPROIC ACID;

AREA UNDER THE CURVE; ARTICLE; ATAXIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG SAFETY; DRUG TOLERANCE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MANIA; MANIC DEPRESSIVE PSYCHOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEDATION; SIDE EFFECT; SUSTAINED RELEASE PREPARATION;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PATIENT ADMISSION; PSYCHIATRIC STATUS RATING SCALES; VALPROIC ACID;

EID: 0032767147     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199908000-00003     Document Type: Article

References (17)

1. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG, Garza-Trevino ES, Risch SC, Goodnick PJ, Morris DD, for the Depakote Mania Study Group. Efficacy of divalproex vs. lithium and placebo in the treatment of mania. JAMA 1994;271:918-24.
2. McElroy SL, Keck PE, Stanton SP, Tugrul KC, Bennett JA, Strakowski SM. A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry 1996;57:142-6.
3. Post RM, Ketter TA, Denicoff K, Pazzaglia PJ, Leverich GS, Marangell LB, Callahan AM, George MS, Frye MA. The place of anticonvulsant therapy in bipolar illness. Psychopharmacology (Berl) 1996;128:115-2.
4. Svestka J, Rysanek R, Ceskova E. Sodium valproate in the treatment of endogenous depressions. Act Nerv Super (Praha) 1990;32:231-2.
5. Hayes SG. Long-term use of valproate in primary psychiatric disorders. J Clin Psychiatry 1989;50:S35-S39.
6. Keck PE Jr, McElroy SL, Nemeroff CB. Anticonvulsants in the treatment of bipolar disorder. J Neuropsychiatry Clin Neurosci 1992;4:395-405.
7. Devinsky O, Leppik I, Willmore LJ, Pellock JM, Dean C, Gates J, Ramsay RE. Safety of intravenous valproate. Ann Neurol 1995;38: 670-4.
8. Wangemann M, Wolf C, Retzow A. Replacement of oral valproate with intravenous valproate: a study on dose finding and bioavailability. Eur J Clin Res 1997;9:209-15.
9. Bech P, Rafaelsen OJ, Kramp P, Bolwig TG. The mania rating scale: scale construction and inter-observer agreement. Neuropharmacology 1978;17:430-1.
10. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-96.
11. Krüger S, Bräuning P, Young LT. Biological treatment of rapid-cycling bipolar disorder. Pharmacopsychiatry 1996;29:167-75.
12. Keck PE Jr, McElroy SL, Tugrul KC, Bennett JA. Valproate oral loading in the treatment of acute mania. J Clin Psychiatry 1993; 54:305-8.
13. Pohlmann-Eden B, Krakow K, Reimers A, Resch S. Parenterale Valproattherapie des posthypoxischen Myoklonus. Proceedings of the 15th Annual Meeting of the Arbeitsgemeinschaft Neurologische Intensivmedizin (ANIM), Hamburg, Germany, 22-24 Jan 1998.
14. Nasrallah HA, Dunner FJ, McCalley-Whitters M. A placebo-controlled trial of valproate in tardive dyskinesia. Biol Psychiatry 1985;20:205-8.
15. Nasrallah HA, Dunner FJ, McCalley-Whitters M, Smith RE. Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: implications for clinical management. J Clin Psychiatry 1986;47:56-9.
16. Fisk GG, York SM. The effect of sodium valproate on tardive dyskinesia - revisited. Br J Psychiatry 1987;150:542-6.
17. Bowden CL. Treatment of bipolar disorder. In: Schatzberg A, Nemeroff C, eds. The American Psychiatric Press textbook of psychopharmacology. Washington (DC): American Psychiatric Press, Inc., 1995:603-14.